Cargando…

Therapeutic response to a novel enzyme-targeting radiosensitization treatment (KORTUC II) for residual lesions in patients with stage IV primary breast cancer, following induction chemotherapy with epirubicin and cyclophosphamide or taxane

Linac-based radiotherapy has a negligible effect on the majority of advanced neoplasms. Therefore, a novel radiosensitization treatment Kochi Oxydol Radiation Therapy for Unresectable Carcinomas II (KORTUC II), which utilizes hydrogen peroxide and sodium hyaluronate was developed. The effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aoyama, Nobutaka, Ogawa, Yasuhiro, Yasuoka, Miki, Iwasa, Hitomi, Miyatake, Kana, Yoshimatsu, Rika, Yamanishi, Tomoaki, Hamada, Norihiko, Tamura, Taiji, Kobayashi, Kana, Murata, Yoriko, Yamagami, Takuji, Miyamura, Mitsuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245061/ https://www.ncbi.nlm.nih.gov/pubmed/28123524 http://dx.doi.org/10.3892/ol.2016.5456

Ejemplares similares

Therapeutic results of a novel enzyme-targeting radiosensitization treatment, Kochi oxydol-radiation therapy for unresectable carcinomas II, in patients with stage I primary breast cancer
por: Aoyama, Nobutaka, et al.
Publicado: (2017)

Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) Using a New Radiosensitization Method (KORTUC II) for Patients with Stage I or II Breast Cancer
por: Ogawa, Yasuhiro, et al.
Publicado: (2015)

Therapeutic response to a novel enzyme-targeting radiosensitization treatment (Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas) in patients with recurrent breast cancer
por: AOYAMA, NOBUTAKA, et al.
Publicado: (2016)

A case of pulmonary pleomorphic carcinoma associated with cystic airspace
por: Iwamura, Mamiko, et al.
Publicado: (2023)

Predicting the pathological invasiveness of early lung adenocarcinoma prior to surgery using Deauville criteria: reliability and validity
por: Nishimori, Miki, et al.
Publicado: (2023)

Evaluation of Changes in Tumor Shadows and Microcalcifications on Mammography Following KORTUC II, a New Radiosensitization Treatment without any Surgical Procedure for Elderly Patients with Stage I and II Breast Cancer
por: Tsuzuki, Akira, et al.
Publicado: (2011)

Development of a Novel Enzyme-Targeting Radiosensitizer (New KORTUC) Using a Gelatin-Based Hydrogel Instead of a Sodium Hyaluronate
por: Morita-Tokuhiro, Shiho, et al.
Publicado: (2016)

Pancreatic FDG uptake on follow-up PET/CT in patients with cancer
por: Iwasa, Hitomi, et al.
Publicado: (2021)

New enzyme-targeting radiosensitizer (KORTUC II) treatment for locally advanced or recurrent breast cancer
por: Shimbo, Taiju, et al.
Publicado: (2021)

Use of a micro-balloon catheter in transcatheter arterial embolization of the renal artery for recurrence of symptoms of autosomal dominant polycystic kidney disease
por: Yamagami, Takuji, et al.
Publicado: (2018)

Spontaneous regression of small cell lung cancer associated with Lambert-Eaton Myasthenic Syndrome: Case report
por: Otani, Michimi, et al.
Publicado: (2023)

Stent-Graft Placement and Coil Embolization for Splenic Artery Aneurysm Derived from Isolated Spontaneous Celiac Artery Dissection
por: Hamada, Ryo, et al.
Publicado: (2023)

Computed Tomography Demonstration of the Production and Distribution of Oxygen Gas Following Intratumoral Injection of a New Radiosensitizer (KORTUC) for Patients with Breast Cancer—Is Intratumoral Injection Not an Ideal Approach to Solve the Major Problem of Tumor Hypoxia in Radiotherapy?
por: Hayashi, Naoya, et al.
Publicado: (2016)

Symptomatic Chronic Severe Stenosis of the Iliac Vein Successfully Treated Endovascularly Using an Interventional Radiology Computed Tomography System
por: Osaki, Marina, et al.
Publicado: (2023)

Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging
por: Yaogawa, Shin, et al.
Publicado: (2015)

Percutaneous transhepatic sclerotherapy with embolization of the drainage vein for a gastric varix
por: Yoshimatsu, Rika, et al.
Publicado: (2014)

Successful removal of a Gunther tulip vena cava filter with wall-embedded hook and migration during a retrieval attempt
por: Yamagami, Takuji, et al.
Publicado: (2013)

Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
por: Wimmer, Kerstin, et al.
Publicado: (2023)

KORTUC, a novel hydrogen peroxide‑based radiosensitizer for the enhancement of brachytherapy in patients with unresectable recurrent uterine cervical cancer
por: Shimbo, Taiju, et al.
Publicado: (2023)

Cyclophosphamide and epirubicin-induced diabetes mellitus in breast cancer: A rare occurrence
por: Sharma, Pramod Kumar, et al.
Publicado: (2016)

Distinct effects of epirubicin, cisplatin and cyclophosphamide on ovarian somatic cells of prepuberal ovaries
por: Marcozzi, Serena, et al.
Publicado: (2019)

Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer
por: Bonneterre, J, et al.
Publicado: (2004)

Cyclophosphamide and epirubicin induce high apoptosis in microglia cells while epirubicin provokes DNA damage and microglial activation at sub-lethal concentrations
por: de la Hoz-Camacho, Rafael, et al.
Publicado: (2022)

Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer
por: Zhang, Minmin, et al.
Publicado: (2016)

Venous Thromboembolism After Removal of Retrievable Inferior Vena Cava Filters
por: Yamagami, Takuji, et al.
Publicado: (2009)

The Role of Divided Injections of a Sclerotic Agent over Two Days in Balloon-Occluded Retrograde Transvenous Obliteration for Large Gastric Varices
por: Yamagami, Takuji, et al.
Publicado: (2013)

Hepatic encephalopathy due to intrahepatic portosystemic venous shunt successfully treated by balloon occluded retrograde transvenous embolization with GDCs
por: Yamagami, Takuji, et al.
Publicado: (2012)

The Risk of Amenorrhea Is Related to Chemotherapy-Induced Leucopenia in Breast Cancer Patients Receiving Epirubicin and Taxane Based Chemotherapy
por: Zhou, Wenbin, et al.
Publicado: (2012)

Dose-Dense Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Node-Positive Breast Cancer
por: Mirzaei, Hamid Reza, et al.
Publicado: (2014)

Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer
por: Veronese, Pedro, et al.
Publicado: (2018)

Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer
por: Mirzaei, Hamid Reza, et al.
Publicado: (2013)

Balloon-occluded retrograde transvenous obliteration successfully performed for a large gastric varix in combination with temporary occlusion of the splenic artery in a child
por: Yamagami, Takuji, et al.
Publicado: (2015)

High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report
por: Nakata, Mio, et al.
Publicado: (2020)

Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34
por: Bartsch, Rupert, et al.
Publicado: (2021)

Taxane & cyclophosphamide vs anthracycline & taxane-based chemotherapy as adjuvant treatment for breast cancer: a pooled analysis of randomized controlled trials by the Hellenic Academy of Oncology
por: Ntellas, Panagiotis, et al.
Publicado: (2019)

Epirubicin
por: Cornish, J., et al.
Publicado: (1988)

Development of Thrombus in a Systemic Vein after Balloon-Occluded Retrograde Transvenous Obliteration of Gastric Varices
por: Yoshimatsu, Rika, et al.
Publicado: (2012)

Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen
por: Bertheau, Philippe, et al.
Publicado: (2007)

Phase II Study of Cyclophosphamide, Epirubicin, Vincristine, Prednisone, and Etoposide (CEOP-E) for Aggressive Non-Hodgkin's Lymphoma
por: Kim, Jong Gwang, et al.
Publicado: (2004)

Neoadjuvant Sequential Docetaxel Followed by High‐Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial
por: Pizzuti, Laura, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qn752je98ctog8nno6efo7jc8l